Private Equity
Location
Rotterdam, The Netherlands
Boston, MA, USA
Private Equity
All Portfolio items
See full Private Equity portfolio
Viroclinics Biosciences is a leader in diagnostic and clinical-trial services. It is one of the few labs in the world able to perform highly complex, specialized diagnostic and preclinical studies in the field of virology. Viroclinics operates globally as the preferred virology testing laboratory for top-ten biopharmaceutical companies.
Gilde acquired a majority share in 2013. During Gilde ownership Viroclinics developed new services for the biopharmaceutical industry, expanded its facilities and tripled its revenues. Viroclinics was sold in 2017 to Parcom Capital.
More Viroclinics Biosciences news
d3 Medicine LLC and Viroclinics Biosciences BV form virology drug development alliance to serve the
Gilde Healthcare Services acquires majority share in Viroclinics Biosciences from Erasmus MC
Private Equity
Zetacom
Zetacom is a market leading systems integrator specialized in healthcare specific communication systems and networking & security solutions in the Netherlands. It specializes in delivering a reliable and innovative communications solution, relying on brands such as BproCare, Nfon, Ascom, IQMessenger,
Private Equity
Stepp Footcare
Stepp Footcare is an integrated footcare provider specializing in podiatry and orthopedic services for patients across the Netherlands. The group provides light-touch care to complex footcare solutions through podiatry, orthopedics, and multidisciplinary treatments. The business adopts a unique approach known
Private Equity
Tandarts Today
Tandarts Today is a fast-growing chain of dental practices and dental laboratories based in Eindhoven, the Netherlands. The chain aims to make a positive impact on dental care by addressing three key challenges: promoting oral health, enhancing the accessibility of
